
Current Price | $17.39 | Mkt Cap | $5.6B |
---|---|---|---|
Open | $17.41 | P/E Ratio | 18.18 |
Prev. Close | $17.39 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $17.34 - $17.52 | Volume | 2,204,488 |
52-Wk Range | $14.87 - $23.40 | Avg. Daily Vol. | 2,609,594 |
A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.
Current Price | $17.39 | Mkt Cap | $5.6B |
---|---|---|---|
Open | $17.41 | P/E Ratio | 18.18 |
Prev. Close | $17.39 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $17.34 - $17.52 | Volume | 2,204,488 |
52-Wk Range | $14.87 - $23.40 | Avg. Daily Vol. | 2,609,594 |
The best Bull and Bear pitches based on recency and number of recommendations.
Strong revenue growth and a oncology portfolio that is growing.
This sector is a scary one! Fear, though, is a fools game. I don't expect this stock to move upwards in the very near future. The cash burn is, well, similar to that Texas A&M bonfire tradition.
Read the most recent pitches from players about EXEL.
Recs
Strong revenue growth and a oncology portfolio that is growing.
Recs
From Fidelity or Zacks November 2021:
Revenue Growth (Last 5 Years) = 92.7%
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 42.1%
Price/Sales (TTM) = 5.2
Recs
First one i picked all by myself, reason:
1. Mkt Cap 7.39B plenty place to grow
2. EPS nxt Yr 94.84%
3.EPS nxt 5Yr 46.00%
4. Sales past 5Yr 107.60%
5. Dept/ Equity 0
Issues:
1. High insider transactions almost 30%
2. Company works on cure for cancer - high volatility
3. EPS this Y -53.80% but justified by Covid-19
Practice and enjoy!
Find the members with the highest scoring picks in EXEL.
beave35 (92.14) Score: +1,144.93
The Score Leader is the player with the highest score across all their picks in EXEL.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
Playa14 | < 20 |
|
![]() |
5Y | $1.27 | +1,269.29% | +92.37% | +1,176.92 | 0 Comment | |
beave35 | 92.14 | 12/23/2014 |
![]() |
5Y | $1.30 | +1,237.59% | +92.66% | +1,144.93 | 0 Comment | |
tomkao | < 20 | 12/15/2014 |
![]() |
5Y | $1.40 | +1,142.14% | +98.79% | +1,043.35 | 0 Comment | |
jack0071 | 66.21 | 12/3/2014 |
![]() |
5Y | $1.43 | +1,116.08% | +93.30% | +1,022.78 | 0 Comment | |
portefeuille | 98.01 |
|
![]() |
NS | $1.44 | +1,107.64% | +98.40% | +1,009.24 | 0 Comment | |
akoniec | 26.69 | 10/9/2014 |
![]() |
3Y | $1.55 | +1,021.94% | +104.11% | +917.83 | 0 Comment | |
dcoyne13 | 46.08 | 9/16/2014 |
![]() |
5Y | $1.62 | +973.39% | +100.46% | +872.93 | 0 Comment | |
foolerhoff | 79.51 | 1/6/2015 |
![]() |
5Y | $1.64 | +960.37% | +98.29% | +862.08 | 0 Comment | |
garisonmp3z | < 20 | 1/5/2015 |
![]() |
5Y | $1.67 | +941.32% | +96.27% | +845.05 | 0 Comment | |
new2fool23 | 40.72 | 1/5/2015 |
![]() |
1Y | $1.67 | +941.32% | +96.27% | +845.05 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.